Clinical Trial Update: The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy [Phase 2, Phase 3]

View source ↗

Summary

A multi-phase study (Phase 2/3) of volanesorsen in familial partial lipodystrophy was terminated; results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Partial Lipodystrophy

Drugs mentioned

• Volanesorsen (volanesorsen)

Snippet

Sponsor: Akcea Therapeutics | Conditions: Familial Partial Lipodystrophy | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2021-10-18